In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy
Mickaël Riou(UCLouvain), Y. Glupczynski(University of Antwerp), Françoise Van Bambeke(UCLouvain), Denis Piérard(Vrije Universiteit Brussel), Daniël De Vos(Queen Astrid Military Hospital), Anne Dediste(Centre Hospitalier Universitaire de Saint-Pierre), Laëtitia Avrain(Coris BioConcept (Belgium)), Sylviane Carbonnelle(UCLouvain), Narcisa Mesaros(UCLouvain), Jean‐Paul Pirnay(Queen Astrid Military Hospital), Florence Bilocq(Queen Astrid Military Hospital), Frédérique Jacobs(Université Libre de Bruxelles), Anne Simon(Cliniques Universitaires Saint-Luc), Paul M. Tulkens(UCLouvain)
Cited by 76
Related Papers
Tackling antibiotic resistance
|Nature Reviews Microbiology|2011|1.1k
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
|Nature Microbiology|2019|817
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
|Clinical Microbiology and Infection|2007|575
Deep Dermatophytosis and Inherited CARD9 Deficiency
|New England Journal of Medicine|2013|403